Teva Pharmaceutical Industries | TEVA - Cost Of Sales

Stock Price
9,231.00
Daily Change
-44.00 -0.47%
Monthly
-13.24%
Yearly
53.52%
Q1 Forecast
9,016.87

Teva Pharmaceutical Industries reported $2.06B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Aspen Pharmacare ZAR 12.73B 1.22B Jun/2025
Cipla INR 29.1B 1.16B Dec/2025
Dr.Reddys Laboratories INR 36.16B 3.75B Dec/2025
Guangzhou Baiy CNY 16.58B 267.46M Sep/2025
Jiangsu Hengrui CNY 1.08B 34.18M Sep/2025
Kalbe Farma IDR 5.46T 523.94B Sep/2025
Richter Gedeon HUF 71.32B 1.01B Sep/2025
Sh Fosun Pharma CNY 5.08B 121.44M Sep/2025
Sun Pharmaceuticals INR 36.77B 348M Dec/2025
Teva Pharmaceutical Industries USD 2.06B 120M Dec/2025